We are live on ! Find out more
CPX

Canaan Partners X Portfolio holdings

AUM $74.7M
1-Year Est. Return 151.56%
This Fund
S&P 500
This Quarter Est. Return
-35.79%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
10 Year Est. Return
AUM
$90.9M
AUM Growth
-$63.9M
Cap. Flow
-$10.1M
Cap. Flow %
-11.07%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NXTC icon
NextCure
NXTC
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXTC icon
1
NextCure
NXTC
$20.8M
$75.2M 82.76%
169,037
-18,833
-10% -$10.1M
IDYA icon
2
IDEAYA Biosciences
IDYA
$3.54B
$11M 12.07%
2,660,713
ITRM
3
DELISTED
Iterum Therapeutics
ITRM
$4.7M 5.17%
115,545

Similar funds

Canaan Partners X's Q1 2020 Portfolio in Review

As of Q1 2020, Canaan Partners X held 3 positions worth $90.9M, down 41% from $155M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners X withdrew a net $10.1M in Q1 2020, reducing 1 holding. Its largest reduction was NextCure, cutting an estimated $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Canaan Partners X's biggest Q1 2020 reduction was NextCure, cutting an estimated $10.1M.
  • Canaan Partners X's ten largest holdings make up 100% of its $90.9M portfolio in Q1 2020.
  • Canaan Partners X opened 0 new positions and closed 0 in Q1 2020.
  • Canaan Partners X's portfolio value fell 41% quarter-over-quarter to $90.9M.

Based on Canaan Partners X's 13F filing for Q1 2020, filed 11 May 2020.